CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO

Introducing the latest stable-labeled antifungal internal standard from Cerilliant, (±)-Voriconazole-D3.

(±)-Voriconazole-D3, 1.0 mg/mL V-036
1.0 mg/mL in Methanol

A stable-labeled internal standard suitable for quantification of voriconazole levels in blood, serum, or plasma by HPLC or LC-MS/MS for applications such as therapeutic drug monitoring or clinical and diagnostic testing. Voriconazole, sold under the trade name Vfend®, is a triazole antifungal drug prescribed for treatment of serious, invasive fungal infections.

Coming soon, Cerilliant will introduce stable-labeled internal standards of Itraconazole-D4, Posaconazole-D4, and Ketoconazole-D4.

Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO 17034 and ISO/IEC 17025 & certified ISO 9001.

All New Product Announcements

© 2021 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
MilliporeSigma is a business of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn